• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗神经病理性配体对西格玛-2 受体调节作用的分子机制:一项计算机研究。

The molecular mechanism of the effects of the anti-neuropathic ligands on the modulation of the Sigma-2 receptor: An in-silico study.

机构信息

Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.

Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.

出版信息

Int J Biol Macromol. 2024 Jan;254(Pt 2):127925. doi: 10.1016/j.ijbiomac.2023.127925. Epub 2023 Nov 7.

DOI:10.1016/j.ijbiomac.2023.127925
PMID:37944735
Abstract

Neuropathic pain (NP) is a prevalent medical condition that lacks an effective treatment. Recently, the Sigma-2 receptor (S2R) has been proposed as a potential therapeutic target for NP. Some highly-selective S2R ligands (UKH1114, CM398, and YTD) have shown promising results in vivo, but the molecular interaction between the S2R and these ligands has been scarcely investigated. This work explores changes in the S2R upon interaction with the three mentioned ligands using in silico approaches. The results indicated that the ICL1, H1, ICL2, and ECL are the most dynamic regions of S2R in all systems. Binding interaction analysis identified amino acids with significant contribution to the binding free energy. Notably, the UKH1114-S2R simulation trajectory revealed that small alterations in the ICL1, H1, ICL2, and ECL form a new stable opening in the S2R, linking the occluded S2R binding pocket to the endoplasmic reticulum lumen, providing more evidence for the assumptions about the EBP and S2R mechanism of function. Further, the agreement between the membrane parameters in our study and experimental values confirms the validity of the MD simulations. Overall, this study provides new insights into the interaction between anti-NP ligands and the S2R.

摘要

神经病理性疼痛(NP)是一种普遍存在的医学病症,目前缺乏有效的治疗方法。最近,Sigma-2 受体(S2R)被认为是治疗 NP 的潜在治疗靶点。一些高选择性的 S2R 配体(UKH1114、CM398 和 YTD)在体内显示出了有希望的结果,但 S2R 与这些配体之间的分子相互作用尚未得到充分研究。本工作使用计算方法探索了 S2R 在与三种提到的配体相互作用时的变化。结果表明,在所有系统中,ICL1、H1、ICL2 和 ECL 是 S2R 中最具动态性的区域。结合相互作用分析确定了对结合自由能有显著贡献的氨基酸。值得注意的是,UKH1114-S2R 模拟轨迹表明,ICL1、H1、ICL2 和 ECL 的微小变化形成了 S2R 中的一个新的稳定开口,将封闭的 S2R 结合口袋与内质网腔连接起来,为关于 EBP 和 S2R 功能机制的假设提供了更多证据。此外,我们研究中的膜参数与实验值之间的一致性证实了 MD 模拟的有效性。总的来说,这项研究提供了关于抗 NP 配体与 S2R 相互作用的新见解。

相似文献

1
The molecular mechanism of the effects of the anti-neuropathic ligands on the modulation of the Sigma-2 receptor: An in-silico study.抗神经病理性配体对西格玛-2 受体调节作用的分子机制:一项计算机研究。
Int J Biol Macromol. 2024 Jan;254(Pt 2):127925. doi: 10.1016/j.ijbiomac.2023.127925. Epub 2023 Nov 7.
2
QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs.基于定量构效关系的计算方法加速 sigma-2 受体 (S2R) 配体作为治疗药物的发现。
Molecules. 2021 Aug 30;26(17):5270. doi: 10.3390/molecules26175270.
3
Discovery of 3-(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligands.发现 3-(2-氨乙基)-噻唑烷-2,4-二酮类化合物作为新型 sigma-1 受体配体。
Chem Biol Drug Des. 2022 Jul;100(1):25-40. doi: 10.1111/cbdd.14047. Epub 2022 Apr 25.
4
Retinal Photoreceptor Protection in an AMD-Related Mouse Model by Selective Sigma-1 or Sigma-2 Receptor Modulation.选择性 sigma-1 或 sigma-2 受体调节剂对 AMD 相关小鼠模型中视网膜感光细胞的保护作用。
Genes (Basel). 2022 Dec 16;13(12):2386. doi: 10.3390/genes13122386.
5
Sigma-2 Receptor Ligand Binding Modulates Association between TSPO and TMEM97.Sigma-2 受体配体结合调节 TSPO 与 TMEM97 之间的关联。
Int J Mol Sci. 2023 Mar 28;24(7):6381. doi: 10.3390/ijms24076381.
6
Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain.新型选择性 sigma-2 受体配体 CM-398 的特性研究——一种治疗神经性疼痛的潜在药物。
Molecules. 2022 Jun 4;27(11):3617. doi: 10.3390/molecules27113617.
7
Another brick in the wall. Validation of the σ1 receptor 3D model by computer-assisted design, synthesis, and activity of new σ1 ligands.又一块砖。通过计算机辅助设计、合成和新 σ1 配体的活性验证 σ1 受体 3D 模型。
Mol Pharm. 2012 Nov 5;9(11):3107-26. doi: 10.1021/mp300233y. Epub 2012 Oct 12.
8
The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes.Sigma-2 受体和孕激素受体膜成分 1 是源自不同基因的不同结合位点。
EBioMedicine. 2015 Oct 19;2(11):1806-13. doi: 10.1016/j.ebiom.2015.10.017. eCollection 2015 Nov.
9
S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling.S2R(Pgrmc1):与细胞色素相关的 sigma-2 受体,调节脂质和药物代谢以及激素信号转导。
Expert Opin Drug Metab Toxicol. 2012 Mar;8(3):361-70. doi: 10.1517/17425255.2012.658367. Epub 2012 Feb 1.
10
New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative.新型 Sigma1 受体被占据配体结合口袋开放机制的新见解:新型双价 RC-33 衍生物的结合。
J Chem Inf Model. 2020 Feb 24;60(2):756-765. doi: 10.1021/acs.jcim.9b00649. Epub 2019 Dec 20.

引用本文的文献

1
Exploring the distinct activation mechanisms of neuromedin B receptor through multiple replica molecular dynamics simulations and Markov state modeling.通过多重复制分子动力学模拟和马尔可夫状态建模探索神经介素B受体的不同激活机制。
Acta Pharmacol Sin. 2025 Jun 27. doi: 10.1038/s41401-025-01603-w.
2
Discovery of Iboga-Derived Ligands for the Sigma‑2 Receptor.伊博格碱衍生的西格玛-2受体配体的发现。
ACS Bio Med Chem Au. 2025 May 12;5(3):379-386. doi: 10.1021/acsbiomedchemau.5c00011. eCollection 2025 Jun 18.
3
Virtual screening and molecular dynamic simulations of dissimilatory sulfite reductase inhibitors for the control of sulphate reducing bacteria.
用于控制硫酸盐还原菌的异化亚硫酸盐还原酶抑制剂的虚拟筛选和分子动力学模拟
In Silico Pharmacol. 2025 Jun 17;13(2):90. doi: 10.1007/s40203-025-00367-9. eCollection 2025.
4
Molecular insight into binding affinities and blockade effects of selected flavonoid compounds on the PD-1/PD-L1 pathway.对选定类黄酮化合物与PD-1/PD-L1通路的结合亲和力和阻断作用的分子洞察。
RSC Adv. 2024 Aug 16;14(36):25908-25917. doi: 10.1039/d4ra03877k.